Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action
Suriyan Ponnusamy, Eric Lattmann, Pornthip Lattmann, Thirumagal Thiyagarajan, Balaram N. Padinjarethalakal, Ramesh Narayanan*
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action'. Together they form a unique fingerprint.